Psychemedics Corp Stock Ownership - Who owns Psychemedics?

Insider buying vs selling

Have Psychemedics Corp insiders been buying or selling?
Charles M. DoucotExecutive Vice President2023-08-1712,700$4.66
Charles M. DoucotExecutive Vice President2023-05-22825$4.93
Michael I. SchafferVP of Laboratory Operations2023-05-22375$4.93
Raymond C. Kubacki Jr.Chairman CEO President2023-05-221,500$4.93
Charles M. DoucotExecutive Vice President2023-05-15900$4.87
Michael I. SchafferVP of Laboratory Operations2023-05-15337$4.87
Raymond C. Kubacki Jr.Chairman CEO President2023-05-151,725$4.87
Michael I. SchafferVP of Laboratory Operations2022-12-16100$4.95

1 of 1

PMD insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when PMD insiders and whales buy or sell their stock.

PMD Shareholders

What type of owners hold Psychemedics Corp stock?
Peter Kamin17.24%999,997$2.92MInsider
H. Wayne Huizenga8.35%484,196$1.41MInsider
Richard T. Christoph6.84%397,100$1.16MInsider
Fred J. Weinert5.08%294,945$861.24kInsider
22nw LP4.73%274,418$801.30kInstitution
Renaissance Technologies LLC4.72%273,663$799.10kInstitution
Vanguard Group Inc4.33%251,151$733.36kInstitution
Raymond C. Kubacki Jr.4.25%246,737$720.47kInsider
Rbf Capital LLC2.49%144,231$421.15kInstitution
Harry F. Connick Sr.1.55%90,112$263.13kInsider

1 of 3

PMD vs Diagnostic & Research Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PMD24.67%49.64%Net Selling
STRR3.56%96.44%Net BuyingNet Buying
TTOO32.87%67.13%Net SellingNet Selling

Psychemedics Stock Ownership FAQ

Who owns Psychemedics?

Psychemedics (NASDAQ: PMD) is owned by 24.67% institutional shareholders, 49.64% Psychemedics insiders, and 25.69% retail investors. Peter Kamin is the largest individual Psychemedics shareholder, owning 999,997.00 shares representing 17.24% of the company. Peter Kamin's Psychemedics shares are currently valued at $2.92M.

If you're new to stock investing, here's how to buy Psychemedics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.